EFFICACY AND SAFETY OF ETANERCEPT TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS. THE RESULTS OF AN OPEN PROSPECTIVE STUDY ON THE BASIS OF THE SCIENTIFIC CENTER OF CHILDREN'S HEALTH (MOSCOW)

• Auteurs principaux: Ekaterina I. Alekseeva (Auteur), Тatyana М. Bzarova (Auteur), Saniya I. Valieva (Auteur), Rina V. Denisova (Auteur), Kseniya B. Isaeva (Auteur), Evgenia G. Chistyakova (Auteur), Alexandra M. Chomahidze (Auteur), Tatyana V. Sleptsova (Auteur), Anna N. Fetisova (Auteur), Оlga L. Lomakina (Auteur), Nikolay I. Taybulatov (Auteur), Anna V. Karaseva (Auteur)
• Format: Livre
• Publié: "Paediatrician" Publishers LLC, 2016-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Addition of genetically engineered biological agents in the paradigm of juvenile idiopathic arthritis (JIA) treatment significantly increased the efficacy of the antirheumatic therapy in patients with this severe chronic disease. Objective. Our aim was to assess the efficacy and safety o...